Dr. Christopher Sayed, MD

NPI: 1225265903
Total Payments
$687,682
2024 Payments
$166,352
Companies
11
Transactions
556
Medicare Patients
1,126
Medicare Billing
$79,403

Payment Breakdown by Category

Other$534,761 (77.8%)
Travel$73,900 (10.7%)
Consulting$69,599 (10.1%)
Food & Beverage$8,687 (1.3%)
Research$724.09 (0.1%)
Education$10.81 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $534,761 194 77.8%
Travel and Lodging $73,900 160 10.7%
Consulting Fee $69,599 41 10.1%
Food and Beverage $8,687 157 1.3%
Unspecified $724.09 2 0.1%
Education $10.81 2 0.0%

Payments by Type

General
$686,958
554 transactions
Research
$724.09
2 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $632,743 506 $0 (2024)
Novartis Pharmaceuticals Corporation $15,078 18 $0 (2024)
UCB, Inc. $10,030 6 $0 (2024)
Incyte Corporation $7,712 7 $0 (2024)
UCB SA $7,319 7 $0 (2024)
Novartis Pharma AG $4,725 2 $0 (2023)
UCB Biosciences Inc. $4,500 5 $0 (2021)
Sandoz Inc. $3,375 1 $0 (2024)
UCB GmBH $1,000 2 $0 (2021)
Almirall LLC $800.00 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $166,352 105 ABBVIE INC. ($138,256)
2023 $94,363 92 AbbVie Inc. ($81,775)
2022 $89,998 76 ABBVIE INC. ($84,783)
2021 $78,642 71 AbbVie Inc. ($76,642)
2020 $38,191 26 AbbVie Inc. ($34,651)
2019 $68,090 63 AbbVie, Inc. ($64,590)
2018 $67,514 53 AbbVie, Inc. ($67,514)
2017 $84,532 70 AbbVie, Inc. ($84,532)

All Payment Transactions

556 individual payment records from CMS Open Payments — Page 1 of 23

Date Company Product Nature Form Amount Type
12/30/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $7,200.00 General
12/30/2024 ABBVIE INC. Travel and Lodging In-kind items and services $147.37 General
12/30/2024 ABBVIE INC. Travel and Lodging In-kind items and services $81.94 General
12/30/2024 ABBVIE INC. Travel and Lodging In-kind items and services $73.50 General
12/20/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: IMMUNOLOGY
12/17/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: IMMUNOLOGY
12/12/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,600.00 General
Category: IMMUNOLOGY
12/11/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $125.00 General
Category: IMMUNOLOGY
12/09/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,600.00 General
Category: IMMUNOLOGY
12/06/2024 ABBVIE INC. Travel and Lodging In-kind items and services $306.20 General
12/06/2024 ABBVIE INC. Food and Beverage In-kind items and services $144.60 General
12/06/2024 ABBVIE INC. Food and Beverage In-kind items and services $93.70 General
12/06/2024 ABBVIE INC. Food and Beverage In-kind items and services $60.24 General
12/05/2024 ABBVIE INC. Travel and Lodging In-kind items and services $1,235.92 General
12/05/2024 ABBVIE INC. RINVOQ (Biological) Travel and Lodging In-kind items and services $931.35 General
Category: IMMUNOLOGY
12/05/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $19.28 General
Category: IMMUNOLOGY
12/02/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: IMMUNOLOGY
11/25/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: IMMUNOLOGY
11/25/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: IMMUNOLOGY
11/21/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $28.80 General
Category: IMMUNOLOGY
11/20/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,600.00 General
Category: IMMUNOLOGY
11/07/2024 ABBVIE INC. RINVOQ (Biological) Travel and Lodging In-kind items and services $1,319.42 General
Category: IMMUNOLOGY
11/07/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $17.53 General
Category: IMMUNOLOGY
11/06/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
Category: IMMUNOLOGY
11/06/2024 ABBVIE INC. RINVOQ (Biological) Travel and Lodging In-kind items and services $1,397.03 General
Category: IMMUNOLOGY

Research Studies & Clinical Trials

Study Name Company Amount Records
Patient and physician preferences for attributes associated with biologic treatments for hidradenitis suppurativa UCB, Inc. $400.00 1
CAIN457M2301,CAIN457M2302 Novartis Pharmaceuticals Corporation $324.09 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 194 368 $60,686 $13,087
2022 8 232 489 $69,645 $18,183
2021 9 312 651 $85,475 $24,636
2020 10 388 731 $97,196 $23,497
Total Patients
1,126
Total Services
2,239
Medicare Billing
$79,403
Procedure Codes
33

All Medicare Procedures & Services

33 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 79 117 $32,479 $7,729 23.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 39 48 $9,408 $2,366 25.1%
17110 Destruction of skin growth, 1-14 growths Office 2023 19 21 $7,104 $1,276 18.0%
17000 Destruction of precancer skin growth, 1 growth Office 2023 23 28 $5,356 $895.54 16.7%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 22 142 $2,757 $425.00 15.4%
11102 Biopsy of related skin growth, first growth Office 2023 12 12 $3,582 $395.94 11.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 91 126 $35,028 $9,867 28.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 34 41 $8,036 $2,262 28.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 13 15 $5,820 $1,885 32.4%
17000 Destruction of precancer skin growth, 1 growth Office 2022 29 39 $7,488 $1,399 18.7%
17110 Destruction of skin growth, 1-14 growths Office 2022 14 18 $5,922 $1,179 19.9%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 27 166 $3,154 $770.01 24.4%
11102 Biopsy of related skin growth, first growth Office 2022 12 13 $3,913 $765.93 19.6%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 12 71 $284.00 $55.99 19.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 83 117 $31,710 $10,860 34.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 55 68 $12,644 $3,816 30.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 17 21 $7,680 $2,712 35.3%
17110 Destruction of up to 14 skin growths Office 2021 24 28 $9,152 $2,187 23.9%
11102 Tangential biopsy of single skin lesion Office 2021 20 21 $6,189 $1,523 24.6%
17000 Destruction of skin growth Office 2021 41 48 $9,174 $1,523 16.6%
17003 Destruction of 2-14 skin growths Office 2021 35 213 $3,951 $1,040 26.3%
11900 Injection of up to 7 skin growths Office 2021 18 28 $4,547 $872.66 19.2%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2021 19 107 $428.00 $101.76 23.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 88 120 $31,269 $8,582 27.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 95 120 $21,183 $5,343 25.2%

About Dr. Christopher Sayed, MD

Dr. Christopher Sayed, MD is a Dermatology healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1225265903.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Sayed, MD has received a total of $687,682 in payments from pharmaceutical and medical device companies, with $166,352 received in 2024. These payments were reported across 556 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($534,761).

As a Medicare-enrolled provider, Sayed has provided services to 1,126 Medicare beneficiaries, totaling 2,239 services with total Medicare billing of $79,403. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Location Chapel Hill, NC
  • Active Since 06/19/2009
  • Last Updated 10/07/2025
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1225265903

Products in Payments

  • RINVOQ (Biological) $233,214
  • Humira (Biological) $150,275
  • HUMIRA (Biological) $149,370
  • COSENTYX (Drug) $10,566
  • Bimzelx (Biological) $9,585
  • SKYRIZI (Biological) $5,368
  • COSENTYX (Biological) $4,725
  • OPZELURA (Drug) $2,522

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Chapel Hill